Local Consolidative Therapy After Dual Immunotherapy Fizzles in Metastatic NSCLC

(MedPage Today) -- Local consolidative therapy (LCT) after induction treatment with nivolumab (Opdivo) plus ipilimumab (Yervoy) failed to improve survival outcomes in patients with metastatic non-small cell lung cancer (NSCLC), including those...